ilmscore | 3 stocks with big earnings surprise - 100% net profit growth?

Predictions from this Video

Total: 22
Correct: 0
Incorrect: 0
Pending: 22
Prediction
Topic
Status
Transformers & Rectifiers India (TRI) plans to expand its manufacturing capacity by 22,000 MVA from its current 40,000 MVA.
"The current capacity of the company is 40,000 MVA i.e. Mega Watts Ampere. They are going to add another 22000 MVA to it."
TRI
Pending
Transformers & Rectifiers India (TRI) plans a capital expenditure of Rs 550 crore over the next 15 months for organic and backward integration growth.
"The company is planning a capex of Rs 550 crore in the next 15 months for its organic and backward integration growth."
TRI
Pending
Transformers & Rectifiers India (TRI) expects revenue visibility for the next 15 to 18 months due to its strong order book.
"The company's strong order book gives it revenue visibility for the next 15 to 18 months"
TRI
Pending
Transformers & Rectifiers India (TRI) has guided to maintain its currently expanded operating profit margin (OPM).
"and it has given guidance to maintain the current OPM that has been expanded."
TRI
Pending
Transformers & Rectifiers India (TRI)'s working capital cycle will lengthen due to extended credit terms of 6+ months.
"the company extended the credit terms to 6 plus months, which will lengthen the working capital cycle."
TRI
Pending
Blue Jet Health Care's management expects the company to maintain its current growth rate and operating margins.
"The management says that it will continue its current growth and margins."
Blue Jet Health Care (Growth & Margins)
Pending
Blue Jet Health Care expects good volume growth in the second half of FY26 for its pharma intermediates, APIs, and sweeteners product categories.
"The company is expecting good volume growth in the second half of FY26 for its product categories such as pharma intermediates, APIs and sweeteners."
Blue Jet Health Care (Volume Growth)
Pending
Blue Jet Health Care's cash realization is predicted to be significantly delayed.
"the cash realization of the company will be significantly delayed."
Blue Jet Health Care (Cash Flow)
Pending
Ashapura Minechem expects its current financial metrics to continue in the future.
"The company says that its current financial metrics will continue in the future also."
Ashapura Minechem (Financial Metrics)
Pending
Ashapura Minechem's cash realization will be significantly delayed, forcing it to depend on short-term loans.
"the company's cash realisation will be significantly delayed, forcing the company to depend on short-term loans."
Ashapura Minechem (Cash Flow & Debt)
Pending
Transformers & Rectifiers India (TRI) plans to add 22,000 MVA to its current capacity of 40,000 MVA.
"They are going to add another 22000 MVA to it."
TRI
Pending
Transformers & Rectifiers India (TRI) plans a capital expenditure of Rs 550 crore in the next 15 months for organic and backward integration growth.
"The company is planning a capex of Rs 550 crore in the next 15 months for its organic and backward integration growth."
TRI
Pending
Transformers & Rectifiers India (TRI) has revenue visibility for the next 15 to 18 months due to its strong order book.
"The company's strong order book gives it revenue visibility for the next 15 to 18 months"
TRI
Pending
Transformers & Rectifiers India (TRI) has guided to maintain its current expanded Operating Profit Margins (OPM).
"it has given guidance to maintain the current OPM that has been expanded."
TRI
Pending
Transformers & Rectifiers India (TRI)'s working capital cycle will lengthen due to extended credit terms of 6+ months.
"the company extended the credit terms to 6 plus months, which will lengthen the working capital cycle."
TRI
Pending
Blue Jet Health Care management expects to continue its current growth and margins.
"The management says that it will continue its current growth and margins."
BLUEJETHL
Pending
Blue Jet Health Care expects good volume growth in the second half of FY26 for pharma intermediates, APIs, and sweeteners.
"The company is expecting good volume growth in the second half of FY26 for its product categories such as pharma intermediates, APIs and sweeteners."
BLUEJETHL
Pending
Blue Jet Health Care's cash realization will be significantly delayed due to an increased cash conversion cycle.
"the cash realization of the company will be significantly delayed."
BLUEJETHL
Pending
Blue Jet Health Care may need to depend on short-term loans.
"Due to which the company may have to depend on short term loans."
BLUEJETHL
Pending
Ashapura Mines expects its current financial metrics to continue in the future.
"The company says that its current financial metrics will continue in the future also."
ASHAPURMIN
Pending
Ashapura Mines' cash realization will be significantly delayed, potentially forcing the company to rely on short-term loans.
"the company's cash realisation will be significantly delayed, forcing the company to depend on short-term loans."
ASHAPURMIN
Pending
Norway will impose a 100% tariff on US pharma imports starting October 1st.
"Norway are going to impose 100% tariff on US pharma imports from the first of October."
Norway Trade Policy
Pending